Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Index (BCI) Registry

NCT04875351 is registered in ClinicalTrials.gov with Biotheranostics, Inc. as lead sponsor.

NCT NCT04875351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04875351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Index (BCI) Registry
Lead sponsor
Biotheranostics, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
April 14, 2021
Completion date
December 31, 2028
Enrollment
3,465 (actual)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer